Skip to content Skip to sidebar Skip to footer

Newsletter

Small Caps Stocks

Atomo Diagnostics (ASX:AT1): Not just another Rapid Diagnostic (RDT) company

Atomo Diagnostics (ASX:AT1) may be written off by some investors just because it is a rapid test kit company. Yes, we know rapid COVID tests were a booming market during the pandemic, but demand is well off all time highs - and indeed, the company no longer performs COVID testing. But there was, is and…

ByNick SundichFebruary 26, 2025

Mankayan: Here’s why Blackstone Minerals is making a big bet with this Fillipino Gold-Copper project

Blackstone Minerals' (ASX:BSX) announcement it was purchasing Mankayan could be lost on most investors as another one of those pivots micro-cap resources companies make. Maybe these companies see it as an opportunity, but there may be an implicit admission of failure in its previous project (in commodity, timing, jurisdiction, or perhaps something else). In this case,…

ByNick SundichFebruary 25, 2025

Recce’s R327G passed its Phase 2 trial with a 93% primary efficiacy endpoint!

Recce Pharmaceuticals (ASX:RCE) has completed its Phase 2 ABSSSI Clinical Trial (Acute Bacterial Skin and Skin Structure Infections) for RECCE® 327 Topical Gel (R327G) and released the results earlier this week. The results were positive, and pave the way for commercialisation as early as 2026. How Recce got to this point Recce is a biotech company focused…

ByNick SundichFebruary 19, 2025

ASX Stocks to buy when interest rates fall: Here are our top 3 sectors

Many investors are asking what ASX Stocks to buy when interest rates fall. When exactly interest rates will fall is anyone's guess, until earlier today (February 18, 2025) when rates were cut from 4.35% to 4.1%. Argue all you like about whether the RBA could've gone further or should've stayed put, but it did what…

ByNick SundichFebruary 18, 2025

Teaminvest Private (ASX:TIP): The ASX’s most unique investment company!

Teaminvest Private (ASX:TIP) may not be as prominent an investment company as Magellan or Wilson, but perhaps it has not been getting the attention it deserves. Originating roughly 2 decades ago as an informal club of business owners for investment education and stock-picking purposes, it has evolved into a company with $1.6bn in funds in its…

ByNick SundichFebruary 13, 2025

Vinyl Group (ASX:VNL) is finding its groove in 2025

Vinyl Group (ASX: VNL) is the only ASX-listed company offering exposure to the music technology and media industries. It has undergone a major transformation in 18 months, now a business with a curated portfolio of interconnected brands that empower everyone in the music ecosystem. Vinyl Group's brands Vinyl has several brands. The most important are: - Jaxsta:…

ByNick SundichFebruary 7, 2025

oOh!media (ASX:OML): Talk of its demise has been greatly exaggerated!

See a massive billboard on an arterial road, and there is a good chance that oOh!media (ASX:OML) was behind it. It is great to have a dominant market position, but this has not prevented shares sliding over 25% in the past 12 months due to cost blowouts and a difficult position with the advertising market.…

ByNick SundichFebruary 6, 2025

Firstwave Cloud Technology (ASX:FCT): A changed company with a plethora of market opportunities

It seems the Tech Wreck is finally over as plenty of technology stocks have been rebounding, although Firstwave Cloud Technology (ASX:FCT) hasn't. One of the arguable reasons is that investors think the company has not changed from what it was a few years ago. The reality is that even though the company has the same…

ByNick SundichFebruary 5, 2025

Alterity Therapeutics (ASX:ATH) more than doubled after its Phase 2 results, but its still only $80m

Alterity Therapeutics (ASX:ATH) hit the jackpot last week. Any clinical-stage biotech achieving a positive Phase 2 outcome is good news, because it depicts that the company's drug is not just safe, but that it works too. But while some companies (like Paradigm (ASX:PAR)) are going after markets with existing drugs that need replacement, Alterity is…

ByNick SundichFebruary 3, 2025

DGL Group (ASX:DGL): Will 2025 be better for DGL and its investors?

Poor DGL Group (ASX:DGL). It was a company that ran hard for several months in 2021, but has substantially retreated as inflation has eroded its margins. Is there hope for investors in this company? DGL Group DGL (ASX:DGL) is an end-to-end chemicals business operating across Australia and New Zealand. The company operates through three segments:…

ByNick SundichJanuary 30, 2025